Overexpression cdc42 attenuates isoflurane-induced neurotoxicity in developmental brain of rats

Biochem Biophys Res Commun. 2017 Aug 26;490(3):719-725. doi: 10.1016/j.bbrc.2017.06.108. Epub 2017 Jun 20.

Abstract

Nowadays many children receive operations with general anesthesia. Isoflurane is a commonly-used general anesthetic. Numbers of studies demonstrated that isoflurane induced neurotoxicity and neurobehavioral deficiency in young rats, however, the underlying mechanism remained unknown. Cell division cycle 42 (cdc42) played an important role in regulating synaptic vesicle trafficking and actin dynamics in neuron, which closely linked to synaptic plasticity and dendritic spine formation. Meanwhile, cdc42 also involved in many neurodegenerative diseases. However, whether cdc42 provided a protective role in isoflurane induced synaptogenesis dysfunction still unknown. As the upstream of cdc42, calcium/Calmodulin-dependent protein kinase II (CaMKII) interacts with ion channels such as VDCCs and N-methyl-d-aspartate receptors (NMDARs), which closely associated with neuroapoptosis and cognitive deficiency in developing brain. The phosphorylation of CaMKIIα at Thr 286 plays an important role in introduction and maintenance of long-term potentiation (LTP). Therefore, we investigated the effect of isoflurane on cdc42 and its upstream Calcium/Calmodulin-dependent protein kinase II (CaMKII) and its downstream p21 activated kinase 3 (PAK3), then determined whether CaMKIIα/cdc42/PAK3 signaling pathway was involved in neurotoxicity and cognitive deficiency induced by isoflurane. Our study found that isoflurane induced neurotoxicity and resulted in cognitive impairment in young rats through suppressed CaMKIIα/cdc42/PAK3 signaling pathway. Cdc42 over-expression could reverse neurotoxicity and improve cognitive impairment induced by isoflurane.

Keywords: Cognitive deficiency; Developmental neurotoxicity; Isoflurane; cdc42.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthetics, Inhalation / adverse effects*
  • Animals
  • Brain / drug effects*
  • Brain / growth & development
  • Brain / metabolism
  • Brain / pathology
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism
  • Cells, Cultured
  • Cognition / drug effects
  • Female
  • Genetic Therapy
  • Isoflurane / adverse effects*
  • Male
  • Neurotoxicity Syndromes / genetics
  • Neurotoxicity Syndromes / pathology
  • Neurotoxicity Syndromes / physiopathology
  • Neurotoxicity Syndromes / therapy*
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction / drug effects
  • Spatial Memory / drug effects
  • Up-Regulation*
  • cdc42 GTP-Binding Protein / genetics*
  • cdc42 GTP-Binding Protein / metabolism
  • p21-Activated Kinases / metabolism

Substances

  • Anesthetics, Inhalation
  • Isoflurane
  • p21-Activated Kinases
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • cdc42 GTP-Binding Protein